And it aligns naturally with how GLP-1 medications affect appetite, since most users find mornings are their least hungry period anyway
Flock G, Baggio LL, Longuet C, Drucker DJ (2007) Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice
The hype is enormous -- which is exactly why I want to give you a clear-eyed, physician's take on what we actually know, what we don't, and what a responsible approach to this peptide looks like
These concerns are based on GH physiology generally rather than large safety trials of these specific peptides, which do not exist
Medication is one part of obesity care
Bei Mangelerscheinungen, wie muskulrer Schwche oder Energiearmut, prfen Mediziner und Medizinerinnen, ob eine Ergnzung ntig ist